FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition used for treatment of allergic response associated with elevating level of IgE and containing one or some compounds of the general formula (A) 
or (B) 
. The composition exhibits enhanced activity.
EFFECT: valuable medicinal properties of compounds and composition.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF BENZIMIDAZOLE AS MODULATING AGENTS OF IGE | 1999 |
|
RU2236221C2 |
| COMPOUNDS AND METHODS OF INHIBITING INTERACTION OF BCL PROTEINS WITH BINDING COMPONENTS | 2005 |
|
RU2416606C2 |
| BENZAMIDE COMPOUNDS USEFUL AS HISTONE DEACETILASE INHIBITORS | 2006 |
|
RU2448965C2 |
| 6-ALCOXYPYRIDOPYRIMIDINES AND PHARMACEUTICAL COMPOUND POSSESSING ACTIVITY OF MAP p38 KINASE INHIBITORS | 2003 |
|
RU2324695C2 |
| SPIROINDOLIN COMPOUNDS FOR TREATING AND PREVENTING THE RESPIRATORY SYNCYTIAL VIRUS (RSV) | 2015 |
|
RU2734248C2 |
| COMPOUNDS AND COMPOSITIONS AS CANAL ACTIVATING PROTEASE INHIBITORS | 2007 |
|
RU2419625C2 |
| 2-AMINO-BENZIMIDAZOLE DERIVATIVES AND USE THEREOF AS 5-LIPOXYGENASE AND/OR PROSTAGLANDIN E-SYNTHASE INHIBITORS | 2015 |
|
RU2732416C2 |
| HETEROCYCLIC COMPOUNDS FOR TYROSINE KINASE 2 ACTIVITY MEDIATION | 2020 |
|
RU2826012C2 |
| BIARYL SUBSTITUTED TRIAZOLES AS SODIUM CHANNEL BLOCATORS | 2004 |
|
RU2356897C2 |
| MACROCYCLIC PYRIDAZINONE DERIVATIVES | 2014 |
|
RU2660435C2 |
